Roundtable Meet the Expert track
MTE #29: Seeing Through the Haze—Mastering Noninvasive Tools for Fibrotic Metabolic Dysfunction–Associated Steatohepatitis (Ticketed)
Sun, Nov 8, 2026 · 12:45–1:30 PM MST Convention Center: Room 1A, Colorado Convention Center
About this session
Accurate identification of fibrotic metabolic dysfunction–associated steatohepatitis (MASH) is critical for risk stratification, treatment selection, and referral. Liver biopsy, however, is neither feasible nor appropriate for most patients. Faculty provide a practical, case-based discussion of noninvasive approaches to detecting fibrotic MASH including serum-based scores, elastography, and emerging biomarkers.
Speakers
-
Duke University School of Medicine
Facilitator
-
Mayo Clinic Rochester
Facilitator